Results 31 to 40 of about 180,202 (208)

The Effect of Mitomycin C on Induction of Shiga Toxin Production in Clinical STEC Isolates

open access: yesToxins
Early determination of the Shiga toxin type of Shiga toxin-producing Escherichia coli (STEC) is crucial for guiding STEC-infected patients for proper and timely treatment and patient care.
Surangi H. Thilakarathna   +2 more
doaj   +1 more source

Geldanamycin Enhances Retrograde Transport of Shiga Toxin in HEp-2 Cells.

open access: yesPLoS ONE, 2015
The heat shock protein 90 (Hsp90) inhibitor geldanamycin (GA) has been shown to alter endosomal sorting, diverting cargo destined for the recycling pathway into the lysosomal pathway. Here we investigated whether GA also affects the sorting of cargo into
Anne Berit Dyve Lingelem   +4 more
doaj   +1 more source

Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease

open access: yesToxins, 2010
Shiga toxin-producing Escherichia coli is a contaminant of food and water that in humans causes a diarrheal prodrome followed by more severe disease of the kidneys and an array of symptoms of the central nervous system.
Tom G. Obrig
doaj   +1 more source

Eeyarestatin 1 interferes with both retrograde and anterograde intracellular trafficking pathways [PDF]

open access: yes, 2011
Background: The small molecule Eeyarestatin I (ESI) inhibits the endoplasmic reticulum (ER)-cytosol dislocation and subsequent degradation of ERAD (ER associated protein degradation) substrates.
Aletrari, Mina-Olga   +28 more
core   +2 more sources

Retrograde transport pathways utilised by viruses and protein toxins [PDF]

open access: yes, 2006
A model has been presented for retrograde transport of certain toxins and viruses from the cell surface to the ER that suggests an obligatory interaction with a glycolipid receptor at the cell surface. Here we review studies on the ER trafficking cholera
J Michael Lord   +9 more
core   +1 more source

Pathogenic Potential to Humans of Bovine Escherichia coli O26, Scotland [PDF]

open access: yes, 2012
Escherichia coli O26 and O157 have similar overall prevalences in cattle in Scotland, but in humans, Shiga toxin–producing E. coli O26 infections are fewer and clinically less severe than E. coli O157 infections.
Low, JC   +53 more
core   +1 more source

Shiga Toxin-Producing E. coli in Animals: Detection, Characterization, and Virulence Assessment

open access: yes, 2021
Cattle and other ruminants are primary reservoirs for Shiga toxin-producing Escherichia coli (STEC) strains which have a highly variable, but unpredictable, pathogenic potential for humans.
Christian Menge   +7 more
core   +1 more source

Shiga Toxin—A Model for Glycolipid-Dependent and Lectin-Driven Endocytosis

open access: yesToxins, 2017
The cellular entry of the bacterial Shiga toxin and the related verotoxins has been scrutinized in quite some detail. This is due to their importance as a threat to human health.
Ludger Johannes
doaj   +1 more source

A brief overview of emergencies and dissemination of Shiga-toxin-producing E. coli (STEC) and Salmonella enterica serovar Typhimurium DT104 in humans and food producing animals

open access: yesArchives of Veterinary Medicine, 2020
Shiga-toxin-producing Escherichia coli (STEC) and Salmonella enterica serovar Typhimurium (STDT104) are foodborne pathogens of public health significance.
Maja Velhner   +6 more
doaj   +1 more source

Nitric oxide‐enhanced Shiga toxin production was regulated by Fur and RecA in enterohemorrhagic Escherichia coli O157

open access: yesMicrobiologyOpen, 2017
Enterohemorrhagic Escherichia coli (EHEC) produces Shiga toxin 1 (Stx1) and Shiga toxin 2 (Stx2). Nitric oxide (NO), which acts as an antimicrobial defense molecule, was found to enhance the production of Stx1 and Stx2 in EHEC under anaerobic conditions.
Kimitoshi Ichimura   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy